CRDF · Cardiff Oncology, Inc.

$0.81 -0.01 (-0.98%) At close · Jul 29

Market Cap

$55.38M

68.37M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$635,000	—	—	$2,266,106	$122,238	—	$3,023,344
Roger Sidhu	CMO	$279,370	—	—	$1,920,275	$74,160	—	$2,273,805
James Levine	CFO	$490,000	—	—	$993,875	$61,740	—	$1,545,615

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$610,584	—	—	$1,471,762	$319,030	—	$2,401,376
Fairooz Kabbinavar	CMO	$494,400	—	—	$591,614	$186,883	—	$1,272,897
James Levine	CFO	$471,194	—	—	$591,614	$203,556	—	$1,266,364

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$594,400	—	—	$672,978	$280,394	—	$1,547,772
Fairooz Kabbinavar	CMO	$443,865	—	—	$601,468	$212,120	—	$1,257,453
James Levine	CFO	$459,236	—	—	$275,678	$182,805	—	$917,719

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tod Smeal	Chief Scientific Officer	$402,716	$40,000	—	$1,487,292	$156,825	—	$2,086,833
Mark Erlander	CEO	$570,600	—	—	$753,272	$266,475	—	$1,590,347
James Levine	CFO	$440,475	—	—	$350,752	$168,252	—	$959,479

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$532,716	—	—	$2,851,972	$250,510	—	$3,635,198
James Levine	CFO	$202,693	—	—	$2,085,227	$179,775	—	$2,467,695
Vicki Kelemen	COO	$359,962	—	—	$1,317,635	$152,280	—	$1,829,877

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$444,764	—	—	$476,380	$229,559	—	$1,150,703
Vicki Kelemen	COO	$322,576	—	—	$269,543	$157,500	—	$749,619

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas H. Adams	CEO	$491,132	—	—	$568,877	$244,625	—	$1,304,634
Mark Erlander	CEO	$398,729	—	—	$255,622	$198,600	—	$852,951

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mark Erlander	CEO	$387,155	—	$34,785	$144,008	$342,576	—	$908,524
Thomas H. Adams	CEO	$286,346	—	—	$11,679	$79,167	—	$377,192

Executive changes

Person	Role	Change	Effective	Filed
Ajay Aggarwal, MD, MBA	Chief Operating Officer	Appointed	2026-04-27	2026-04-09
Josh Muntner	Chief Financial Officer	Appointed	2026-04-06	2026-04-09
Mark Erlander	director	Resigned	2026-03-27	2026-04-02
Mani Mohindru	interim CEO	Appointed	2026-01-27	2026-01-27

Key facts CIK 1213037 CUSIP 14147L108 13F (30d) 23 filings 23 filers Visit website Investor relations